Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romit Chakrabarty

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Chemotherapy and Pharmacology|March 15, 2017
A phase II study of REOLYSIN<sup>®</sup> (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanomaDevalingam Mahalingam, Christos Fountzilas, Jennifer Moseley, et al.
Investigational New Drugs|October 15, 2013
Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley ratsRomit Chakrabarty, Hue Tran, Iohann Boulay, et al.
Applied Microbiology and Biotechnology|January 15, 2014
Evaluation of homogeneity and genetic stability of REOLYSIN (pelareorep) by complete genome sequencing of reovirus after large scale productionRomit Chakrabarty, Hue Tran, Yves Fortin, et al.
Cancers|May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN<sup>®</sup>) in Combination with Gemcitabine for Patients with Advanced Pancreatic AdenocarcinomaDevalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Journal of Biotechnology|April 23, 2013
Transcriptome analysis based on next-generation sequencing of non-model plants producing specialized metabolites of biotechnological interestMei Xiao, Ye Zhang, Xue Chen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Chemotherapy and Pharmacology|March 15, 2017
A phase II study of REOLYSIN<sup>®</sup> (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanomaDevalingam Mahalingam, Christos Fountzilas, Jennifer Moseley, et al.
Investigational New Drugs|October 15, 2013
Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley ratsRomit Chakrabarty, Hue Tran, Iohann Boulay, et al.
Applied Microbiology and Biotechnology|January 15, 2014
Evaluation of homogeneity and genetic stability of REOLYSIN (pelareorep) by complete genome sequencing of reovirus after large scale productionRomit Chakrabarty, Hue Tran, Yves Fortin, et al.
Cancers|May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN<sup>®</sup>) in Combination with Gemcitabine for Patients with Advanced Pancreatic AdenocarcinomaDevalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Journal of Biotechnology|April 23, 2013
Transcriptome analysis based on next-generation sequencing of non-model plants producing specialized metabolites of biotechnological interestMei Xiao, Ye Zhang, Xue Chen, et al.
Pageof 2